Mimeault M, Hauke R, Batra S K
Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Clin Pharmacol Ther. 2007 Sep;82(3):252-64. doi: 10.1038/sj.clpt.6100301. Epub 2007 Aug 1.
Basic and clinical research accomplished during the last few years on embryonic, fetal, amniotic, umbilical cord blood, and adult stem cells has constituted a revolution in regenerative medicine and cancer therapies by providing the possibility of generating multiple therapeutically useful cell types. These new cells could be used for treating numerous genetic and degenerative disorders. Among them, age-related functional defects, hematopoietic and immune system disorders, heart failures, chronic liver injuries, diabetes, Parkinson's and Alzheimer's diseases, arthritis, and muscular, skin, lung, eye, and digestive disorders as well as aggressive and recurrent cancers could be successfully treated by stem cell-based therapies. This review focuses on the recent advancements in adult stem cell biology in normal and pathological conditions. We describe how these results have improved our understanding on critical and unique functions of these rare sub-populations of multipotent and undifferentiated cells with an unlimited self-renewal capacity and high plasticity. Finally, we discuss some major advances to translate the experimental models on ex vivo and in vivo expanded and/or differentiated stem cells into clinical applications for the development of novel cellular therapies aimed at repairing genetically altered or damaged tissues/organs in humans. A particular emphasis is made on the therapeutic potential of different tissue-resident adult stem cell types and their in vivo modulation for treating and curing specific pathological disorders.
过去几年间,在胚胎干细胞、胎儿干细胞、羊水干细胞、脐带血干细胞和成体干细胞方面所取得的基础研究和临床研究成果,为再生医学和癌症治疗带来了一场革命,因为这些研究成果提供了生成多种具有治疗用途细胞类型的可能性。这些新细胞可用于治疗多种遗传和退行性疾病。其中,与年龄相关的功能缺陷、造血和免疫系统疾病、心力衰竭、慢性肝损伤、糖尿病、帕金森病和阿尔茨海默病、关节炎以及肌肉、皮肤、肺、眼和消化系统疾病,还有侵袭性和复发性癌症,都可以通过基于干细胞的疗法成功治疗。本综述聚焦于正常和病理条件下成体干细胞生物学的最新进展。我们描述了这些研究结果如何增进了我们对这些具有无限自我更新能力和高可塑性的多能未分化细胞罕见亚群的关键独特功能的理解。最后,我们讨论了一些重大进展,即将体外和体内扩增及/或分化的干细胞实验模型转化为临床应用,以开发旨在修复人类基因改变或受损组织/器官的新型细胞疗法。我们特别强调了不同组织驻留成体干细胞类型的治疗潜力及其在体内的调节作用,以治疗和治愈特定的病理疾病。